Category: Company news

Evaluations continue successfully

Review of first five patients at St Peter’s and continuation of the trial Following the start of the continuous, automatic glucose monitoring trial at St Peter’s Hospital Chertsey a review has been successfully carried out on the data received from the first five patients. The trial now continues with further patients. In addition to the…
Read more »

Probe systems in clinical use

Probe is pleased to announce that it has started clinical evaluations of its MicroEye and ContinuMon monitoring systems. The first evaluation has commenced at St Peter’s Hospital Chertsey UK. Subsequent clinical work will commence in other centres in the New Year.

Latest Publication from the Nanodem project

The latest publication from the Nanodem project shows the progress made in Point of Care (POC) testing systems for use with Probe’s MicroEye sampling system. Please click here for full details

Probe Scientific Ltd and University College London

Medical device company, Probe Scientific, is developing its existing microdialysis technology to provide therapeutic antibiotic drug monitoring for healthcare practitioners at the bedside. They will work with UCL’s Professor Mervyn Singer, Head of the Centre for Intensive Care, and his group of leading experts in sepsis, infection, and blood monitoring; to validate the technology for…
Read more »